For: | Cheng ZQ, Liu TM, Ren PF, Chen C, Wang YL, Dai Y, Zhang X. Duodenal-jejunal bypass reduces serum ceramides via inhibiting intestinal bile acid-farnesoid X receptor pathway. World J Gastroenterol 2022; 28(31): 4328-4337 [PMID: 36159007 DOI: 10.3748/wjg.v28.i31.4328] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i31/4328.htm |
Number | Citing Articles |
1 |
Zi-Tian Liu, Guang-Wei Yang, Xiang Zhao, Shuo-Hui Dong, Yang Jiao, Zheng Ge, Ao Yu, Xi-Qiang Zhang, Xin-Zhen Xu, Zhi-Qiang Cheng, Xiang Zhang, Ke-Xin Wang. Growth hormone improves insulin resistance in visceral adipose tissue after duodenal-jejunal bypass by regulating adiponectin secretion. World Journal of Diabetes 2024; 15(6): 1340-1352 doi: 10.4239/wjd.v15.i6.1340
|
2 |
Guangwei Yang, Zitian Liu, Shuohui Dong, Xiang Zhao, Zheng Ge, Zhiqiang Cheng, Xiang Zhang, Kexin Wang. Duodenal‐jejunal bypass surgery activates eNOS and enhances antioxidant system by activating AMPK pathway to improve heart oxidative stress in diabetic cardiomyopathy rats. Journal of Diabetes 2024; 16(7) doi: 10.1111/1753-0407.13516
|